Intraprostatic and Bladder-Neck Injection of Botulinum A Toxin in Treatment of Males with Bladder-Neck Dyssynergia: A Pilot Study

European Urology

Volumn 53, Issue 3, 2008, Pages 620-627

  Lim, Sey Kiat ^a   Quek, Pearllyn L C ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Bladder outlet obstruction; Bladder neck dyssynergia; Botulinum A toxin; Primary bladder neck obstruction

Indexed keywords

BOTULINUM TOXIN A; PROMETHAZINE;

ADULT; ARTICLE; BLADDER NECK DYSSYNERGIA; BLADDER OBSTRUCTION; CLINICAL ARTICLE; DISEASE DURATION; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; MICTURITION; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; URINE FLOW RATE; URODYNAMICS;

ADULT; BOTULINUM TOXIN TYPE A; CYSTOSCOPY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATE; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE; URINATION; URODYNAMICS;

EID: 38749090600     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.001     Document Type: Article

References (28)

1. Huckabay C., and Nitti V.W. Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep 6 (2005) 271-275
2. Nitti V.W., Lefkowitz G., Ficazzola M., et al. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures. J Urol 168 (2002) 135-138
3. Yang S.S., Wang C.C., Hsieh J.H., et al. Alpha1-adrenergic blockers in young men with primary bladder neck obstruction. J Urol 168 (2002) 571-574
4. Norlen L.J., and Blaivas J.G. Unsuspected proximal urethral obstruction in young and middle-aged men. J Urol 135 (1986) 972-980
5. Crowe R., Noble J., Robson T., Soediono, Milroy E.J.G., and Burnstock G. An increase of neuropeptide Y but not nitric oxide synthase-immunoreactive nerves in the bladder neck from male patients with bladder neck dyssynergia. J Urol 154 (1995) 1231-1237
6. Yalla S.V., and Resnick N.M. Initiation of voiding in humans: the nature and temporal relationship of urethral sphincter responses. J Urol 157 (1997) 590-595
7. Trockman B.A., Gerspach J., Dmochowski R., Haab F., Zimmern P.E., et al. Primary bladder neck obstruction: urodynamic finding and treatment results in 36 men. J Urol 156 (1996) 1418-1420
8. Kaplan S.A., Te A.E., and Jacobs B.Z. Urodynamics evidence of vesicle neck obstruction in men with misdiagnosed chronic bacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol 152 (1994) 2063-2065
9. Sirls L.T., Ganabathi K., Zimmern P.E., et al. Transurethral incision of the prostate: an objective and subjective evaluation of long term efficacy. J Urol 150 (1993) 1615-1621
10. Kochakarn W., and Lertsithichai P. Unilateral transurethral incision for primary bladder neck obstruction: symptom relief and fertility preservation. World J Urol 21 (2003) 159-162
11. Katz P.G., Greenstein A., Ratliff J.E., et al. Transurethral incision of bladder neck and prostate. J Urol 144 (1990) 694-696
12. Patel A.K., Patterson J.M., and Chapple C.R. Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results. Eur Urol 50 (2006) 684-710
13. Werner M., Schmid D.M., and Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 192 (2005) 1735-1740
14. Schmid D., Sauermann P., Werner M., et al. Experience with 100 cases treated with botulinum-a toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177-185
15. Apostolidis A., Dasgupta P., Fowler C.J., et al. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49 (2006) 644-650
16. MacKenzie I., Burnstock G., and Dolly J.O. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7 (1982) 997-1006
17. Dressler D., Saberi F.A., and Barbosa E.R. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr 63 (2005) 180-185
18. Maria G., Brisinda G., Civello I.M., et al. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62 (2003) 259-265
19. Chuang Y.C., Chiang P., Huang C., et al. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66 (2005) 775-779
20. Kuo H.C. Prostate botulinum A toxin injection-an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65 (2005) 670-674
21. Guercini F., Giannantoni A., Bard R.L., et al. Intraprostatic botulinum toxin injection in patients with severe benign prostatic hyperplasia: a multicenter feasibility study. J Urol 173 (2005) 376-377
22. Park D.S., Cho T.W., Lee Y.K., et al. Evaluation of short term clinical effects and presumptive mechanism Botulinum type A toxin as a treatment modality of benign prostatic hyperplasia. Yonsei Med J 47 (2006) 706-714
23. Doggweiler R., Zermann D.H., Ishigooka M., and Schmidt R.A. Botox induced prostatic involution. Prostate 37 (1998) 44-50
24. Kim H.J., Seo K., Yum K.W., Oh Y.-S., Yoon T.G., and Yoon S.M. Effects of botulinum toxin type A on the superior cervical ganglia in rabbits. Auton Neurosci 102 (2002) 8-12
25. Kirby R.S., Roehrborn C., Boyle P., et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the prospective European doxazosin and combination therapy (PREDICT) trial. Urology 61 (2003) 119-126
26. Andersen M., Dahlstrand C., and Hoye K. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia. Eur Urol 38 (2000) 400-409
27. Kim N.H., Chung J.H., Park R.H., and Park J.B. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 115 (2005) 919-930
28. Lee H.J., Lee D.W., Park Y.H., et al. Botulinum toxin a for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 30 (2004) 867-871